Trafalgar International, Inc. (GCAN)
Trafalgar International, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Miami, FL, US. The stock last traded at $1.60, up 0.00% on the session, giving a market capitalisation of $318,200. On trailing twelve-month figures it carries a trailing P/E of 0.38, a net margin of 0.0%. Its beta of 0.34 implies it has historically moved less than the broad market.
Trafalgar International, Inc. focuses on acquiring, developing and growing businesses in the financial services, technology and intellectual property sectors. The company was formerly known as The Greater Cannabis Company, Inc. and changed its name to Trafalgar International, Inc. in July 2026. The company was founded in 2014 and is based in Miami, Florida.
Trafalgar International, Inc. is most often compared with the following Healthcare names: